Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology Samples
NCT02580799 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2016-02-22
Summary
A multi-center non-interventional, in-vitro trial for evaluation of concordance of the results for Human Epidermal Growth Factor Receptor 2 (HER2) expression by the Immunohistochemical (IHC) method in pathological samples collected from participants with breast cancer.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 18 Years
- Max Age
- 74 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2014-10-31
- Completion
- 2014-10-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics
NCT01775514 ·Status: COMPLETED
-
HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
NCT06238284 ·Status: UNKNOWN
-
Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin Blocks
NCT02852096 ·Status: UNKNOWN ·Phase: NA
-
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
NCT05902494 ·Status: COMPLETED
-
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
NCT00581750 ·Status: COMPLETED
-
A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan
NCT06925113 ·Status: COMPLETED
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer
NCT02610218 ·Status: UNKNOWN
-
Tumor-Derived FGF19
NCT06068257 ·Status: RECRUITING
-
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
NCT05587439 ·Status: RECRUITING
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
NCT06765850 ·Status: RECRUITING
-
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
NCT05812027 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer
NCT05708599 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Thiol Disulfide Balance in Cervix Cancer
NCT04258553 ·Status: COMPLETED
-
Molecular Analysis of the Sloane Project
NCT05868252 ·Status: UNKNOWN
-
Screening Study for Participants With Malignant Tumors
NCT05419375 ·Status: COMPLETED ·Phase: PHASE2
-
Family History Study on Cancer Risk
NCT04145388 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
NCT00369109 ·Status: COMPLETED
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer
NCT04175067 ·Status: COMPLETED
-
Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma
NCT06309459 ·Status: COMPLETED
-
Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi
NCT03160183 ·Status: COMPLETED
-
A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma
NCT06658587 ·Status: NOT_YET_RECRUITING